Cubist Systematic Strategies’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-26,744
| Closed | -$251K | – | 2807 |
|
|
2020
Q3 | $251K | Buy |
26,744
+6,784
| +34% | +$64.5K | ﹤0.01% | 2043 |
|
|
2020
Q2 | $153K | Buy |
19,960
+7,887
| +65% | +$60.3K | ﹤0.01% | 2114 |
|
|
2020
Q1 | $75K | Buy |
+12,073
| New | +$106K | ﹤0.01% | 1954 |
|
|
2019
Q4 | – | Sell |
-68,278
| Closed | -$789K | – | 2626 |
|
|
2019
Q3 | $789K | Sell |
68,278
-36,612
| -35% | -$385K | 0.02% | 1092 |
|
|
2019
Q2 | $1.05M | Buy |
+104,890
| New | +$1.13M | 0.02% | 1013 |
|
|
2019
Q1 | – | Sell |
-35,338
| Closed | -$537K | – | 2498 |
|
|
2018
Q4 | $537K | Buy |
35,338
+28,064
| +386% | +$535K | 0.03% | 922 |
|
|
2018
Q3 | $145K | Buy |
+7,274
| New | +$166K | 0.01% | 1513 |
|
|
2017
Q4 | – | Sell |
-10,653
| Closed | -$197K | – | 2181 |
|
|
2017
Q3 | $197K | Buy |
+10,653
| New | +$199K | 0.01% | 1454 |
|
|
2017
Q1 | – | Sell |
-6,928
| Closed | -$241K | – | 1959 |
|
|
2016
Q4 | $241K | Buy |
+6,928
| New | +$207K | 0.02% | 1128 |
|
|
2016
Q3 | – | Sell |
-1,305
| Closed | -$31K | – | 1952 |
|
|
2016
Q2 | $31K | Buy |
+1,305
| New | +$29.9K | ﹤0.01% | 1619 |
|
|
2015
Q4 | – | Sell |
-7,900
| Closed | -$314K | – | 2042 |
|
|
2015
Q3 | $314K | Sell |
7,900
-31,572
| -80% | -$1.96M | 0.02% | 1208 |
|
|
2015
Q2 | $2.73M | Buy |
39,472
+34,422
| +682% | +$2.17M | 0.13% | 188 |
|
|
2015
Q1 | $276K | Buy |
5,050
+3,550
| +237% | +$169K | 0.01% | 1310 |
|
|
2014
Q4 | $64K | Buy |
+1,500
| New | +$54.2K | ﹤0.01% | 1755 |
|
Cubist Systematic Strategies's AMAG Position: Q4 2020 in Review
Cubist Systematic Strategies sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 26,744 shares — an estimated $251K sold.
Cubist Systematic Strategies first reported a position in AMAG in Q4 2014 and held it in 14 quarters. The position peaked at $2.73M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Cubist Systematic Strategies reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Cubist Systematic Strategies sold 26,744 AMAG Pharmaceuticals shares in Q4 2020, an estimated $251K.
- Cubist Systematic Strategies first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 14 quarters.
- Cubist Systematic Strategies's AMAG Pharmaceuticals position peaked at $2.73M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Cubist Systematic Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.